Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: cochlear cells

June 3, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Nano-Enabled Toxicity of Pharmaceutical Excipients

Nanotechnology has brought revolutionary advances in the pharmaceutical field. Among drug delivery systems, nanocarriers, which enhance the solubility, stability and

Continue reading

February 23, 2026 CD as API / Pharma applications

The mechanism of ototoxicity studied by using HPBCD

The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a

Continue reading

July 14, 2025 CD as API / Pharma applications

Novel insights from a quantitative analysis of cyclodextrin-induced ototoxicity in mice

The cochlea is vulnerable to various pathological conditions, with sensory cells typically being the primary targets of damage. However, supporting

Continue reading

January 29, 2024 CD as API / Pharma applications

Impact of cholesterol homeostasis within cochlear cells on auditory development and hearing loss

Cholesterol is the most abundant sterol molecule in mammalian cells, which not only constitutes the cell membrane but also plays

Continue reading

Recent Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Special issue: Cyclodextrin‑Based Advanced Formulations
  • Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
  • Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (362)
  • CD derivatives (446)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (835)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (429)
  • Other industrial use (115)
  • Pharma applications (1,245)
  • Supramolecular systems (45)
  • Uncategorized (178)

Top Posts

  • HPBCD beads for drug delivery
  • FDA Clears Cyclarity’s UDP-003 Trial for Heart Disease
  • Obituary for Prof. Dr.-Ing. Wolfram Saenger
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • Cyclodextrin for treating lymphedema
  • Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin?
  • Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function
  • Effects of water matrix constituents on micropollutant removal by activated carbon and b-cyclodextrin polymer adsorbents
  • Green Extraction Techniques of Bioactive Compounds: A State-of-the-Art Review

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,472 other subscribers
Loading Comments...